| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/13/2003 | WO2002099134B1 Methods and compositions for assessment of pulmonary function and disorders |
| 02/13/2003 | WO2002099092A8 Production of recombinant human lysosomal alpha-mannosidase |
| 02/13/2003 | WO2002098455A8 Production of recombinant human arylsulfatase a |
| 02/13/2003 | WO2002096948A9 Engineered tetravalent antibodies and methods of use |
| 02/13/2003 | WO2002096947A8 The lectin-like domain of thrombomodulin and its therapeutic use |
| 02/13/2003 | WO2002090378A3 Haplotypes of the ces2 gene |
| 02/13/2003 | WO2002088328A8 Method for generating highly active human dendritic cells from monocytes |
| 02/13/2003 | WO2002086145A3 Biological sample processing methods and compositions that include surfactants |
| 02/13/2003 | WO2002080849A3 Chemotherapeutic induction of egr-1 promoter activity |
| 02/13/2003 | WO2002079380A3 Disruptions in gaba receptor rh02 subunit, methods adn uses thereof |
| 02/13/2003 | WO2002079228A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/13/2003 | WO2002072855A3 Process for the preparation of d-pantothenic acid and/or salts thereof |
| 02/13/2003 | WO2002072032A3 Compounds and methods for identifying, staging and treating cutaneous t-cell lymphoma |
| 02/13/2003 | WO2002070648A3 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 02/13/2003 | WO2002069232A3 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 02/13/2003 | WO2002066514A3 Artificial fusion proteins with reduced immunogenicity |
| 02/13/2003 | WO2002062849A3 Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof |
| 02/13/2003 | WO2002062296A3 Methods and compositions useful for stimulating an immune response |
| 02/13/2003 | WO2002060584A3 Method for carrying out a biochemical protocol in continuous flow in a microreactor |
| 02/13/2003 | WO2002059351A3 Accessing microbial diversity by ecological methods |
| 02/13/2003 | WO2002055556A3 Regulation of human voltage gated potassium channel protein kv2.2 |
| 02/13/2003 | WO2002053741A8 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/13/2003 | WO2002048321A3 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 02/13/2003 | WO2002042118A3 Oil maintenance indicator |
| 02/13/2003 | WO2002041691A3 Transgenic or recombinant non-human mammals and their uses in screening psycho-active medicines |
| 02/13/2003 | WO2002040688A9 Maize yellow stripe1 and related genes |
| 02/13/2003 | WO2002038805A3 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 02/13/2003 | WO2002038780A3 Use of a nucleic acid to provide a plant with resistance to attack by a pathogen |
| 02/13/2003 | WO2002038765A9 Dna encoding bovine immunoglobulin a inducing protein and uses therefor |
| 02/13/2003 | WO2002034886A9 Isolation of binding proteins with high affinity to ligands |
| 02/13/2003 | WO2002033110A3 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 02/13/2003 | WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2002026789A3 Nucleotide sequences mediating male fertility and method of using same |
| 02/13/2003 | WO2002026778A3 Isolated peptides which bind to hla-c molecules and uses thereof |
| 02/13/2003 | WO2002020752A3 Cloned cells, embryos, and avians and methods, of producing them |
| 02/13/2003 | WO2002018443A3 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 02/13/2003 | WO2002016641A3 Reinforced lead screw with spring biased anti-backlash nut |
| 02/13/2003 | WO2002016594A3 Methods and reagents for molecular cloning |
| 02/13/2003 | WO2002016572A9 Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature |
| 02/13/2003 | WO2002014520A3 Process for inducing direct somatic embryogenesis and secondary embryogenesis in monocotyledonous plant cells, and rapidly regenerating fertile plants |
| 02/13/2003 | WO2002009755A3 Apo-2l receptor agonist and cpt-11 synergism |
| 02/13/2003 | WO2002004613A3 Isolated polynucleotides encoding human 5'-nucleotide cn-ia and cn-ib, isolated proteins encoded by the same, and methods utilizing the same |
| 02/13/2003 | WO2002003793A3 Transgenic mice containing targeted gene disruptions |
| 02/13/2003 | WO2002000863A3 32140, a novel human aldehyde dehydrogenase and uses therefor |
| 02/13/2003 | WO2002000862A8 32447, a novel human acyltransferase and uses thereof |
| 02/13/2003 | WO2002000702A3 Regulation of human epidermis-specific serine protease |
| 02/13/2003 | WO2001096023A3 Dielectrically-engineered microparticles |
| 02/13/2003 | WO2001094951A9 Inhibitors of c-reactive protein induced inflammation |
| 02/13/2003 | WO2001092567A3 Novel target genes for diseases of the heart |
| 02/13/2003 | WO2001092331A8 Compositions and methods for the treatment of immune related diseases |
| 02/13/2003 | WO2001087286A3 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 02/13/2003 | WO2001083796A3 Adenoviral vectors for tumor specific gene expression and uses thereof |
| 02/13/2003 | WO2001067855A3 Transgenic mice containing targeted gene disruptions |
| 02/13/2003 | WO2001057277A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver |
| 02/13/2003 | WO2001057270A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and hbl 100 cells |
| 02/13/2003 | US20030033639 Generation of transgenic plant; obtain stem, transform cells, propagate transformed cells |
| 02/13/2003 | US20030033638 Production of transgenic plants of the tagetes species |
| 02/13/2003 | US20030033637 Generation of transforming growth factor protein in plants; obtain plant, transform with vector containing transforming growth factor, culture and propagate plant, recover protein |
| 02/13/2003 | US20030033636 Expression of eukaryotic peptides in plant plastids |
| 02/13/2003 | US20030033635 Nucleotide sequences for eliminating unwanted nucleic acids in agricultural food products |
| 02/13/2003 | US20030033634 Nucleotide sequences for use in monitoring sugar depletion in plants |
| 02/13/2003 | US20030033633 Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants |
| 02/13/2003 | US20030033632 Polypeptide for use in the generation of disease resistant plants |
| 02/13/2003 | US20030033630 Use of duckweed in high throughput screening |
| 02/13/2003 | US20030033629 RecA proteins |
| 02/13/2003 | US20030033628 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |
| 02/13/2003 | US20030033627 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |
| 02/13/2003 | US20030033626 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms |
| 02/13/2003 | US20030033625 Transgenic mice containing CLCN4 chloride ion channel gene disruptions |
| 02/13/2003 | US20030033624 Expression vector for use as nucleotide sequences transfer tool in gene therapy |
| 02/13/2003 | US20030033623 Animal model for use in the treatment and diagnosis of nervous system disorders |
| 02/13/2003 | US20030033622 Generation of trangeenic insects; obtain embryo, inject with transposable expression vector coding heterologous protein, detect insertion of sequences into embryonic genome, expression of reporter molecule indicates insertion |
| 02/13/2003 | US20030033621 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease |
| 02/13/2003 | US20030033620 Animal model for parkinson's disease and method of making same |
| 02/13/2003 | US20030033619 Kainate receptor subunit GLUR7 polymorphisms for diagnosing predisposition and for therapy of mood disorders |
| 02/13/2003 | US20030033618 Generation of mammalian protein in trangenic animal; obtain embryo, transform with expression vector, propagate embryo to maturity, induce lactation, recover milk, isolate membran protein |
| 02/13/2003 | US20030033617 Generation of nuclear transfer embryo; obtain cells, remove nucleus from one, transfer to enucleated cell, transform with artifical chromosome, recover and monitor gene expresion in the cell |
| 02/13/2003 | US20030033616 Imaging marker transgenes |
| 02/13/2003 | US20030033615 Animal model for use in the evaluation of carcinogenicity or toxigenicity of a drug or therapeutic compound |
| 02/13/2003 | US20030033614 Method for identifying hormonally modulated genes |
| 02/13/2003 | US20030033279 Methods and apparatus for high-speed approximate sub-string searches |
| 02/13/2003 | US20030032793 Gene of PGT of human brain type |
| 02/13/2003 | US20030032792 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of gastrointestinal, crohn's, inflammatory bowel, diabetes and cancer, |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032788 Oligonucleotide sequences for use in the prevention and for controlling the consumption of alcoholic beverages |
| 02/13/2003 | US20030032786 Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM2 |
| 02/13/2003 | US20030032785 Detection of ligand and ligand sequences in sample; obtain nucleotide sequence samples, partitioning sample, incubate with primers, propagate and amplify sequences |
| 02/13/2003 | US20030032781 Antibody for use in the treatment of cancer |
| 02/13/2003 | US20030032777 Precursor polypeptide of phytosulfokine derived from Arabidopsis thaliana and a gene encoding said polypeptide |
| 02/13/2003 | US20030032776 Polynucleotide encoding a novel human potassium channel beta-subunit, K+Mbeta1 |
| 02/13/2003 | US20030032775 Effector proteins of rapamycin |
| 02/13/2003 | US20030032772 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/13/2003 | US20030032615 Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response |
| 02/13/2003 | US20030032613 Novel adenovirus gene therapy vehicle and cell line |
| 02/13/2003 | US20030032612 Inhibit expression of a gene in the operon; reducing bacterial resistance to antibiotics |
| 02/13/2003 | US20030032610 Administering one or more oligonucleotides which share at least 50% nucleotide sequence identity with (TTAGGG)n or oligonucleotides which share at least 50% nucleotide sequence identity with the human telomere overhang repeat. |
| 02/13/2003 | US20030032607 Oligonucleotides targeted to nucleic acids encoding human raf and capable of inhibiting raf expression; may have chemical modifications at one or more positions and may be chimeric; inhibiting hyperproliferation of cells |
| 02/13/2003 | US20030032588 Glucagon antagonists |